克罗拉滨能抑制核苷酸还原酶，IC50为65 nM，还能抑制DNA聚合酶活性，是嘌呤核苷抗代谢产物。在至少两种其他类型的治疗已经失败后，这是FDA批准的治疗儿童复发或难治性急性淋巴细胞白血病（ALL)的药物。
(2R,3S,4R,5R)-5-((Benzoyloxy)methyl)-3-fluorotetrahydrofuran-2,4-diyl dibenzoate
1,3,5-Tri-O-benzoyl-a-D-ribofuranose
(2S,3R,4R,5R)-2-Acetoxy-5-((benzoyloxy)methyl)tetrahydrofuran-3,4-diyl dibenzoate
(4S,5R)-4-Hydroxy-5-(hydroxymethyl)dihydrofuran-2(3H)-one
2-Deoxy-2-fluoro-alpha-D-arabinofuranosyl bromide 3,5-dibenzoate
(2R,3R,4S,5R)-5-(6-Amino-2-chloro-9H-purin-9-yl)-4-fluoro-2-(hydroxymethyl)tetrahydrofuran-3-ol
2,6-Dichloropurine
2-Chloro-7H-purin-6-amine
